People have been talking about terraforming and colonizing Mars since the beginning of space travel, and in the past few years that ambition seems to ...
An ounce of prevention | Interview with Dr. Michael Ristow (part iii)
For the most part, we know how to mitigate the chronic diseases that plague people in their older years–eat healthily from early on, and get ple...
Using neurodegeneration to fight cancer safely and effectively
The "magic bullet", a universal solution to target all cancer types without harming normal body cells, is what early cancer researchers thought we'd i...
The chaotic inner life of cancer
(Continued from part I) Most people who’ve meet cancer on the battlefield of treatment, doctors or patients, come away with the impression of a robust...
Glucosamine: The new metformin? | Interview with Dr. Michael Ristow (part ii)
Last week when we heard from Dr. Ristow, he turned the outdated notion of the “free radical theory of aging” on its head, and demonstrated that antiox...
Free radicals are not your enemy | An interview with Dr. Michael Ristow (part i)
Dr. Michael Ristow, a professor of energy metabolism at ETH Zurich, bases much of his research into aging on a premise that many of us will find surpr...
This chip can pluck the bad apples out of your blood
Many years from now, you’re reclining in one of the many gray-blue armchairs that line the walls of a clinic. Your arm is propped up on a collapsible ...
James Peyer: Where are stem cell therapies headed?
Someday soon we may be able to replace tissues or entire organs with those grown from a patients’ own stem cells… but just how soon? What ...
Will this protein help speed up clinical trials?
Biomarkers are a big deal in the clinical world: if as a doctor you’re able to take one simple measurement that allows you to look into a patient’s fu...
James Peyer: Why primary indications matter
“Aging” isn’t a disease as recognized by the FDA–not yet anyway. But then how will the companies trialing anti-aging drugs eve...